Kihei, United States
Orthogonal Thinker, founded in 2016 and headquartered in the United States, is pioneering a transformative approach in the Biotechnology industry with its innovative concept of "Farma", underscoring "Food as Medicine". The company’s mission centers on providing access to nature's most potent health solutions, thereby setting new industry benchmarks for transparency and quality.
Orthogonal Thinker’s diverse focus spans several key areas: Psilocybin & Wellness, with an emphasis on empowering emotional intelligence through DEA-registered psychoactive compounds; Whole Food innovations, including the expansion of Maui Raw production; and a wide array of Cannabis | Hemp | CBD products.
The company operates a platform model enabling shareholders to benefit from multiple holdings and subsidiaries. Orthogonal Thinker last secured a $6.00M Seed Round on April 29, 2020, with investment backing from Republic capital and Das & Co., suggesting confidence in their innovative direction and growth potential.
